Abstract:Deregulation of lipid composition in adipose tissue adjacent to breast tumour is observed in ex vivo and animal models. Novel non-invasive magnetic resonance imaging (MRI) allows rapid lipid mapping of the human whole breast. We set out to elucidate the spatial heterogeneity of peri-tumoural lipid composition in postmenopausal patients with oestrogen receptor positive (ER +) breast cancer. Thirteen participants (mean age, 62 ± [SD] 6 years) with ER + breast cancer and 13 age-matched postmenopausal healthy controls were scanned on MRI. The number of double bonds in triglycerides was computed from MRI images to derive lipid composition maps of monounsaturated, polyunsaturated, and saturated fatty acids (MUFA, PUFA, SFA). The spatial heterogeneity measures (mean, median, skewness, entropy and kurtosis) of lipid composition in the peri-tumoural region and the whole breast of participants and in the whole breast of controls were computed. The Ki-67 proliferative activity marker and CD163 antibody on tumour-associated macrophages were assessed histologically. Mann Whitney U or Wilcoxon tests and Spearman's coefficients were used to assess group differences and correlations, respectively. For comparison against the whole breast in participants, peri-tumoural MUFA had a lower mean (median (IQR), 0.40 (0.02), p < .001), lower median (0.42 (0.02), p < .001), a negative skewness with lower magnitude (− 1.65 (0.77), p = .001), higher entropy (4.35 (0.64), p = .007) and lower kurtosis (5.13 (3.99), p = .001). Peri-tumoural PUFA had a lower mean ( p < .001), lower median ( p < .001), a positive skewness with higher magnitude ( p = .005) and lower entropy ( p = .002). Peri-tumoural SFA had a higher mean ( p < .001), higher median ( p < .001), a positive skewness with lower magnitude ( p < .001) and lower entropy ( p = .012). For comparison against the whole breast in controls, peri-tumoural MUFA had a negative skewness with lower magnitude ( p = .01) and lower kurtosis ( p = .009), however there was no difference in PUFA or SFA. CD163 moderately correlated with peri-tumoural MUFA skewness ( r s = − .64), PUFA entropy ( r s = .63) and SFA skewness ( r s = .59). There was a lower MUFA and PUFA while a higher SFA, and a higher heterogeneity of MUFA while a lower heterogeneity of PUFA and SFA, in the peri-tumoural region in comparison with the whole breast tissue. The degree of lipid deregulation was associated with inflammation as indicated by CD163 antibody on macrophages, serving as potential marker for early diagnosis and response to therapy.

Alteration in lipid composition differentiates breast cancer tissues: a 1H HRMAS NMR metabolomic study

Multimodal Metabolic Imaging Reveals Pigment Reduction and Lipid Accumulation in Metastatic Melanoma

Association of altered metabolic profiles and long non-coding RNAs expression with disease severity in breast cancer patients: analysis by 1H NMR spectroscopy and RT-q-PCR

Metabolomics of Breast Cancer Using High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopy: Correlations with 18F-FDG Positron Emission Tomography-Computed Tomography, Dynamic Contrast-Enhanced and Diffusion-Weighted Imaging MRI

Exploring lipidomic profiles and their correlation with hormone receptor and HER2 status in breast cancer

High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance Spectroscopy of Paired Clinical Liver Tissue Samples from Hepatocellular Cancer and Surrounding Region

Upregulation of lipid metabolism genes in the breast prior to cancer diagnosis

Comprehensive Serum Lipidomic Analyses Reveal Potential Biomarkers for Malignant Breast Cancer: A Case-Control Study.

Metabolic Portraits of Breast Cancer by HR MAS MR Spectroscopy of Intact Tissue Samples

In vivo MR spectroscopy for breast cancer diagnosis

Mass Spectrometry-Based Quantitative Metabolomics Revealed A Distinct Lipid Profile In Breast Cancer Patients

Comprehensive lipid profiling of plasma in patients with benign breast tumor and breast cancer reveals novel biomarkers

Leveraging ML for profiling lipidomic alterations in breast cancer tissues: a methodological perspective

Quantitative global lipidomics analysis of patients with ovarian cancer versus benign adnexal mass

Alterations of Ceramides, Acylcarnitines, GlyceroLPLs, and Amines in NSCLC Tissues

A Spectroscopic Technique to Simultaneously Characterize Fatty Acid Uptake, Mitochondrial Activity, Vascularity, and Oxygen Saturation for Longitudinal Studies In Vivo

The Metabolomic Characteristics and Dysregulation of Fatty Acid Esters of Hydroxy Fatty Acids in Breast Cancer

Magnetic Resonance Imaging (MRI) and MR Spectroscopic Methods in Understanding Breast Cancer Biology and Metabolism

[Lipidomic markers of tumor progress in breast cancer patients]

Spatial heterogeneity of peri-tumoural lipid composition in postmenopausal patients with oestrogen receptor positive breast cancer

Application of in vivo MR methods in the study of breast cancer metabolism